Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) and cholinergic. Metabolic disorders are the most severe adverse
drug reactions (ADRs) and lead to cardiovascular
Meshcheryakova, S.,
Shumadalova, A.,
Beylerli, O.,
Gareev, I.,
Zhao, S.,
Wu, J. (2022) of the bacterial chromosome. 12 new uracil S-derivatives were obtained and
tested for their in vitro antimicrobial
Lu, Enzhou,
Gareev, Ilgiz,
Yuan, Chao,
Liang, Yanchao,
Sun, Jingxian,
Chen, Xin,
Beylerli, Ozal,
Sufianov, Albert,
Zhao, Shiguang,
Yang, Guang (2022) supplemented by postoperative chemotherapy. Platinum
drugs are a class of chemotherapeutic
drugs that affect
Pashirova, T.N.,
Shaihutdinova, Z.M.,
Vandyukov, A.E.,
Lyubina, A.P.,
Amerhanova, S.K.,
Voloshina, A.D.,
Samorodov, A.V.,
Souto, E.B.,
Mironov, V.F.,
Mironov, V.F. (2022) -positive and gram-negative bacteria, fungi, hemolytic activity, cell toxicity (MTT-
test) and in vitro anticoagulant
Background: To examine fundamental characteristics of clinical trials with therapeutic
drug